#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    VEXAS syndrome Antiphospholipid syndrome Leukaemia Epilepsy Retinal dystrophy Synovial sarcoma Arteriosclerosis Cutaneous T-cell lymphoma stage II B-cell small lymphocytic lymphoma Retinoblastoma Still's disease Squamous cell carcinoma of the cervix Krabbe's disease Spinal muscular atrophy Hodgkin's disease recurrent More trials…

    Learn about Rare Diseases

    Short-bowel syndrome Hairy cell leukaemia recurrent Osteosarcoma – Trials in Disease Wiskott-Aldrich syndrome – Diagnostics Haemophilia Advanced systemic mastocytosis Hairy cell leukaemia recurrent – Treatment Von Willebrand’s disease – Basic Information Systemic sclerosis pulmonary Alagille syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    FLUCLOXACILLIN SODIUM LY3537031 Laronidase Nemtabrutinib Bleomycin L-ALANINE ANTI-GD2-800CW H2-Receptor Antagonist R-Azasetron Besilate Anthoxanthum Odoratum REGN7544 Levothyroxine Sodium Leflunomide Heparin Sodium CARBOMER 980 ANHYDROUS CALCIUM FOLINATE Emraclidine Trifluridine Oxycodone Hydrochloride Bcmacp03 More therapies…

    Learn about Your Condition

    Post procedural complication Encephalitis autoimmune Angina pectoris Insulin resistance Sickle cell disease Developmental hip dysplasia Malignant melanoma stage II Mucopolysaccharidosis Haemolytic uraemic syndrome Advanced systemic mastocytosis Anal cancer Oesophageal cancer metastatic Penile squamous cell carcinoma Cognitive disorder Oesophageal carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • Study on Cannabidiol and Aripiprazole for Treating Substance-Induced Psychosis in Young Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Psychotic behaviour
    • Psychotic disorder
    Investigated Drugs:
    • Aripiprazole
    • Cannabidiol
    Italy

  • Study on the Effectiveness and Safety of Intranasal BPL-003 for Patients with Treatment-Resistant Depression

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Major depression
    Germany Poland Spain

  • Study on the Effects of BH-200 (Nelivaptan) for Patients with Major Depressive Disorder

    Not recruiting

    2 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Nelivaptan
    Bulgaria Estonia Germany Lithuania Poland Slovakia +1

  • Study on Psilocybin for Patients with Treatment-Resistant Depression

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Psilocybine
    France

  • Study on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Aticaprant
    Belgium Bulgaria Czechia France Hungary Italy +5

  • Study on Semaglutide for Preventing Metabolic Issues in Prediabetic or Diabetic Patients with Schizophrenia on Clozapine or Olanzapine

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Semaglutide
    Denmark
Previous Page
1 … 32 33 34 35 36 … 40
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!